Benyoucef Samira, Surinya Katharina H, Hadaschik Dirk, Siddle Kenneth
Department of Clinical Biochemistry, Addenbrooke's Hospital, University of Cambridge, Cambridge CB2 2QR, UK.
Biochem J. 2007 May 1;403(3):603-13. doi: 10.1042/BJ20061709.
The IR (insulin receptor) and IGFR (type I insulin-like growth factor receptor) are found as homodimers, but the respective pro-receptors can also heterodimerize to form insulin-IGF hybrid receptors. There are conflicting data on the ligand affinity of hybrids, and especially on the influence of different IR isoforms. To investigate further the contribution of individual ligand binding epitopes to affinity and specificity in the IR/IGFR family, we generated hybrids incorporating both IR isoforms (A and B) and IR/IGFR domain-swap chimaeras, by ectopic co-expression of receptor constructs in Chinese hamster ovary cells, and studied ligand binding using both radioligand competition and bioluminescence resonance energy transfer assays. We found that IR-A-IGFR and IR-B-IGFR hybrids bound insulin with similar relatively low affinity, which was intermediate between that of homodimeric IR and homodimeric IGFR. However, both IR-A-IGFR and IR-B-IGFR hybrids bound IGF-I and IGF-II with high affinity, at a level comparable with homodimeric IGFR. Incorporation of a significant fraction of either IR-A or IR-B into hybrids resulted in abrogation of insulin- but not IGF-I-stimulated autophosphorylation. We conclude that the sequence of 12 amino acids encoded by exon 11 of the IR gene has little or no effect on ligand binding and activation of IR-IGFR hybrids, and that hybrid receptors bind IGFs but not insulin at physiological concentrations regardless of the IR isoform they contained. To reconstitute high affinity insulin binding within a hybrid receptor, chimaeras in which the IGFR L1 or L2 domains had been replaced by equivalent IR domains were co-expressed with full-length IR-A or IR-B. In the context of an IR-A-IGFR hybrid, replacement of IR residues 325-524 (containing the L2 domain and part of the first fibronectin domain) with the corresponding IGFR sequence increased the affinity for insulin by 20-fold. We conclude that the L2 and/or first fibronectin domains of IR contribute in trans with the L1 domain to create a high affinity insulin-binding site within a dimeric receptor.
胰岛素受体(IR)和I型胰岛素样生长因子受体(IGFR)以同二聚体形式存在,但各自的前体受体也可形成异二聚体,进而形成胰岛素-IGF杂交受体。关于杂交体的配体亲和力,尤其是不同IR异构体的影响,存在相互矛盾的数据。为了进一步研究单个配体结合表位对IR/IGFR家族亲和力和特异性的贡献,我们通过在中国仓鼠卵巢细胞中异位共表达受体构建体,生成了包含两种IR异构体(A和B)的杂交体以及IR/IGFR结构域交换嵌合体,并使用放射性配体竞争和生物发光共振能量转移测定法研究了配体结合情况。我们发现,IR-A-IGFR和IR-B-IGFR杂交体以相似的相对低亲和力结合胰岛素,该亲和力介于同二聚体IR和同二聚体IGFR之间。然而,IR-A-IGFR和IR-B-IGFR杂交体均以高亲和力结合IGF-I和IGF-II,其水平与同二聚体IGFR相当。将相当一部分IR-A或IR-B掺入杂交体中会导致胰岛素刺激的自磷酸化被消除,但IGF-I刺激的自磷酸化不受影响。我们得出结论,IR基因外显子11编码的12个氨基酸序列对IR-IGFR杂交体的配体结合和激活几乎没有影响,并且杂交受体在生理浓度下结合IGFs而非胰岛素,无论其包含何种IR异构体。为了在杂交受体内重建高亲和力胰岛素结合,将IGFR的L1或L2结构域替换为等效IR结构域的嵌合体与全长IR-A或IR-B共表达。在IR-A-IGFR杂交体的情况下,用相应的IGFR序列替换IR的325-524位残基(包含L2结构域和部分第一个纤连蛋白结构域)可使胰岛素亲和力提高20倍。我们得出结论,IR的L2和/或第一个纤连蛋白结构域与L1结构域相互作用,在二聚体受体内形成高亲和力胰岛素结合位点。